Abstract
One hundred and fourteen Corynebacterium diphtheriae, toxigenic, gravis type, pharyngeal carriers were identified during a diphtheria epidemic in Elgin, Texas. All carriers were treated with erythromycin estolate, 1 g/day in divided doses for 6 days. Serial pharyngeal cultures were obtained in order to monitor the bacteriological response. Seventy-two carriers had positive cultures immediately prior to the start of therapy, and only these individuals were considered in the analysis of the effects of erythromycin. Forty-eight hours after institution of therapy, 96% of the carriers had become culture negative; all were negative by the 4th day of therapy, and all remained culture negative while taking the drug. Two days after cessation of therapy, all but one (99%) were culture negative. However, upon reculture 2 weeks later, 15 (21%) had relapsed to the carrier state. There were no significant differences in the serum diphtheria antitoxin levels, immunization status, age, sex, or socioeconomic status of those who relapsed and those who remained culture negative. This study demonstrates that erythromycin is effective in converting carriers to culture-negative status, but when given for only 6 days it is associated with large numbers of relapses. Because previous studies have not included follow-up cultures 2 weeks after therapy, it is suggested that all C. diphtheriae carriers be treated with either erythromycin or penicillin and that all be recultured at a minimum of 2 weeks after completion of therapy to assure eradication of the diphtheria organisms.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HAIGHT T. H., FINLAND M. Laboratory and clinical studies on erythromycin. N Engl J Med. 1952 Aug 14;247(7):227–232. doi: 10.1056/NEJM195208142470701. [DOI] [PubMed] [Google Scholar]
- HEILMAN F. R., HERRELL W. E., WELLMAN W. E., GERACI J. E. Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin). Proc Staff Meet Mayo Clin. 1952 Jul 16;27(15):285–304. [PubMed] [Google Scholar]
- McCloskey R. V., Eller J. J., Green M., Mauney C. U., Richards S. E. The 1970 epidemic of diphtheria in San Antonio. Ann Intern Med. 1971 Oct;75(4):495–503. doi: 10.7326/0003-4819-75-4-495. [DOI] [PubMed] [Google Scholar]
- McLaughlin J. V., Bickham S. T., Wiggins G. L., Larsen S. A., Balows A., Jones W. L. Antibiotic susceptibility patterns of recent isolates of Corynebacterium diphtheriae. Appl Microbiol. 1971 May;21(5):844–851. doi: 10.1128/am.21.5.844-851.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHUBERT J. H., CORNELL R. G. Determination of diphtheria and tetanus antitoxin by the hemagglutination test in comparison with tests in vivo. J Lab Clin Med. 1958 Nov;52(5):737–743. [PubMed] [Google Scholar]
- STAVITSKY A. B. Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells. J Immunol. 1954 May;72(5):360–367. [PubMed] [Google Scholar]
- Zalma V. M., Older J. J., Brooks G. F. The Austin, Texas, diphtheria outbreak. Clinical and epidemiological aspects. JAMA. 1970 Mar 30;211(13):2125–2129. [PubMed] [Google Scholar]